For its first fiscal quarter (ending March 31), West Pharmaceutical Services Inc (NYSE: WST) has reported E.P.S. of $1.57 compared to $1.88 a year ago. For the latest four quarters through March 31, E.P.S. were $7.67 compared to $7.41 a year ago.
Recent Price Action
On 4/25/24, West Pharmaceutical Services Inc (NYSE: WST) stock declined by -4.5%, closing at $368.18. Moreover, unusually high trading volume at 154% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -2.4% during the last week.
Current PriceTarget Research Rating
WST is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
West Pharmaceutical Services has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. West Pharmaceutical Services has a poor Power Rating of 27 and a very low Appreciation Score of 8, producing the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment